iPremom is a healthcare technology company that develops molecular diagnostics for the early detection of pregnancy complications.
iPremom has raised $17.4M in total funding. The most recent round was Seed. The last funding was announced in September 2026.
iPremom's investors include Asabys Partners, Amadeus Capital Partners, APEX Ventures, EIC Accelerator.
iPremom is headquartered in Paterna, Spain.
iPremom is a healthcare technology company that develops molecular diagnostics for the early detection of pregnancy complications.
iPremom is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"iPremom — Funding & Investors." VCBacked, September 2, 2026, https://www.vcbacked.co/company/ipremom. Accessed October 1, 2026.
VCBacked. (2026). iPremom — Funding & Investors. Retrieved October 1, 2026, from https://www.vcbacked.co/company/ipremom
{{cite web |title=iPremom — Funding & Investors |url=https://www.vcbacked.co/company/ipremom |website=VCBacked |access-date=October 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated